the industry to optimize R&D resources to more rapidly bring
Question # 00211250
Posted By:
Updated on: 03/01/2016 08:19 PM Due on: 03/31/2016
Recently, there have been several consolidations in the economy, the biotech industry being one. With the creation of fewer "Biotech giants worldwide", will this lead to stronger monopoly power, thus potentially contributing to rising healthcare costs (prescription drugs), or is it a necessity of the industry to optimize R&D resources to more rapidly bring new, critical medicines to market?
-
Rating:
/5
Solution: the industry to optimize R&D resources to more rapidly bring